151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old

BACKGROUND: Pneumococcal conjugate vaccine (PCV13) was recommended in series with PPSV23 for all US adults ≥65 years in late 2014. We evaluated effectiveness of PCV13 against invasive pneumococcal disease (IPD) among Medicare beneficiaries ≥65 years old to assess this new policy. METHODS: We linked...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Forum Infect Dis
Hauptverfasser: Pilishvili, Tamara, Almendares, Olivia M, Nanduri, Srinivas, Warnock, Rob, Wu, Xiyuan, McKean, Stephen, Kelman, Jeffrey, Farley, Monica M, Schaffner, William, Thomas, Ann, Reingold, Arthur, Harrison, Lee H, Holtzman, Corinne, Rowlands, Jemma V, Petit, Susan, Barnes, Meghan, Torres, Salina, Beall, Bernard, Whitney, Cynthia
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2018
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252531/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge